Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study | CLINICAL LUNG CANCER |